These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 25608973

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dental panoramic indices and fractal dimension measurements in osteogenesis imperfecta children under pamidronate treatment.
    Apolinário AC, Sindeaux R, de Souza Figueiredo PT, Guimarães AT, Acevedo AC, Castro LC, de Paula AP, de Paula LM, de Melo NS, Leite AF.
    Dentomaxillofac Radiol; 2016; 45(4):20150400. PubMed ID: 26954289
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Musculoskeletal functional outcomes in children with osteogenesis imperfecta: associations with disease severity and pamidronate therapy.
    Sousa T, Bompadre V, White KK.
    J Pediatr Orthop; 2014 Jan; 34(1):118-22. PubMed ID: 23863411
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate.
    Lindahl K, Kindmark A, Rubin CJ, Malmgren B, Grigelioniene G, Söderhäll S, Ljunggren Ö, Åström E.
    Bone; 2016 Jun; 87():11-8. PubMed ID: 26957348
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bone mineral density and fracture rate in response to intravenous and oral bisphosphonates in adult osteogenesis imperfecta.
    Shapiro JR, Thompson CB, Wu Y, Nunes M, Gillen C.
    Calcif Tissue Int; 2010 Aug; 87(2):120-9. PubMed ID: 20544187
    [Abstract] [Full Text] [Related]

  • 17. Therapy with pamidronate in children with osteogenesis imperfecta.
    Marginean O, Tamasanu RC, Mang N, Mozos I, Brad GF.
    Drug Des Devel Ther; 2017 Aug; 11():2507-2515. PubMed ID: 28894358
    [Abstract] [Full Text] [Related]

  • 18. Pamidronate in children with osteogenesis imperfecta: histomorphometric effects of long-term therapy.
    Rauch F, Travers R, Glorieux FH.
    J Clin Endocrinol Metab; 2006 Feb; 91(2):511-6. PubMed ID: 16291701
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.